Armored bicistronic CAR T cells with dominant-negative TGF-β receptor II to overcome resistance in glioblastoma.
Li N, Rodriguez JL, Yin Y, Logun MT, Zhang L, Yu S, Hicks KA, Zhang JV, Zhang L, Xie C, Wang J, Wang T, Xu J, Fraietta JA, Binder ZA, Lin Z, O'Rourke DM.
Li N, et al. Among authors: rodriguez jl.
Mol Ther. 2024 Jul 31:S1525-0016(24)00476-3. doi: 10.1016/j.ymthe.2024.07.020. Online ahead of print.
Mol Ther. 2024.
PMID: 39086131